Animal studies have revealed gut microbial and metabolic pathways of blood pressure (BP)
regulation, yet few epidemiological studies have collected microbiota and metabolomics …

Background: Sex differences in the pathogenesis of hypertension exist. While gut microbiota
(GM) has been associated with hypertension, it is unclear whether there are sex-linked …

Recent evidence supports a role for the gut microbiota in hypertension, but whether
ambulatory blood pressure is associated with gut microbiota and their metabolites remains …

Animal models support a role for the gut microbiota in the development of hypertension.
There has been a lack of epidemiological cohort studies to confirm these findings in human …

Background: Blood pressure (BP) variability is an independent risk factor for cardiovascular
events. Recent evidence supports a role for the gut microbiota in BP regulation. However …

Background Recently, the potential role of gut microbiome in metabolic diseases has been
revealed, especially in cardiovascular diseases. Hypertension is one of the most prevalent …

Abstract Background Black Americans have greater rates, severity and resistance to
treatment of hypertension than White Americans. The gut microbiota and its metabolites may …

Background The human gut microbiota (GM) is involved in the pathogenesis of hypertension
(HTN), and could be affected by various factors, including sex and geography. However …

Background Several small‐scale animal studies have suggested that gut microbiota and
blood pressure (BP) are linked. However, results from human studies remain scarce and …

Significance: Hypertension (HTN) has a complex etiology that is characterized by genetic
and environmental factors. It has become a global health burden leading to cardiovascular …